APA (7th ed.) Citation

Dabbaghi, R., Safaralizadeh, R., Rahmani, S., Barpour, N., Hosseinpourfeizi, M., Rajabi, A., & Baradaran, B. (2023). The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients. BMC Research Notes, 16(1), 1. https://doi.org/10.1186/s13104-023-06556-z

Chicago Style (17th ed.) Citation

Dabbaghi, Rozhin, Reza Safaralizadeh, Shima Rahmani, Nesa Barpour, Mohammadali Hosseinpourfeizi, Ali Rajabi, and Behzad Baradaran. "The Effect of Glatiramer Acetate, IFNβ-1a, Fingolimod, and Dimethyl Fumarate on the Expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS Patients." BMC Research Notes 16, no. 1 (2023): 1. https://doi.org/10.1186/s13104-023-06556-z.

MLA (9th ed.) Citation

Dabbaghi, Rozhin, et al. "The Effect of Glatiramer Acetate, IFNβ-1a, Fingolimod, and Dimethyl Fumarate on the Expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS Patients." BMC Research Notes, vol. 16, no. 1, 2023, p. 1, https://doi.org/10.1186/s13104-023-06556-z.